Physician profile
Michael O Larson
NPI 1417452376
$1,095.72
in general payments reported to CMS, 2019-2025
12 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $439 · 2023: $163 · 2024: $219 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $656.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $410.29 | 2022 | |
| Integra Lifesciences Corporation | $173.13 | 2024 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Genzyme Corporation | $151.87 | 2025 | |
| Med-El Corporation | $143.75 | 2023 | Bci 602 Kit, Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit |
| Glaxosmithkline, LLC. | $80.66 | 2024-2025 | Nucala |
| Smith+Nephew, INC. | $29.45 | 2025 | Tula |
| Advanced Bionics, LLC | $26.52 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Optinose US, INC. | $18.94 | 2023 | |
| Phathom Pharmaceuticals, INC. | $18.24 | 2024 | Voquezna |
| Karl Storz Endoscopy-America | $14.67 | 2022 | |
| Regeneron Pharmaceuticals, INC. | $14.10 | 2022 | |
| Medtronic, INC. | $14.10 | 2025 | Slide-On Endosheath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.